| abstract |
A pharmaceutical composition for use to facilitate or increase the activity of regulatory T lymphocytes and to reduce or inhibit the activity of pathogenic Th17 lymphocytes in an immune disease, comprising N-ethyl-N- (4-fluorophenyl) -biguanide or a Pharmaceutically acceptable salt thereof as an active ingredient. |